Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark C. McKenna Insider Profile
4 Followers
Mark C. McKenna, President, Salix at Bausch Health Companies, holds 6.96K shares in NewAmsterdam Pharma Company (Ticker: NAMS), holds 20.00K shares in Apogee Therapeutics (Ticker: APGE), holds 0.00 shares in Prometheus Biosciences (Ticker: RXDX).
Mark C. McKenna Bausch Health Companies (BHC)President, Salix
Bausch Health Companies (BHC)
President, Salix
Ranked #46,122 out of 100,370 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+6.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark C. McKenna holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 21, 2019 - Aug 21, 2020
Return:+26.80%
The most profitable trade made by Mark C. McKenna
Mark C. McKenna's Trading History
Bausch Health Companies
Aug 21, 2019
President, Salix
Informative Sell
235.17K
$155.05K
Prometheus Biosciences
Jun 16, 2023
―
Uninformative Sell
―
$0.00
Apogee Therapeutics
Dec 16, 2024
Director
Informative Buy
990.77K
$806.40K
Spyre Therapeutics
―
Director
―
―
NewAmsterdam Pharma Company
Jan 08, 2025
Director
Uninformative Buy
―
$144.63K
List of latest transactions for each holding click on a transaction to see Mark C. McKenna's performance on stock
You May Also Like
Mark C. McKenna insider profile FAQ
What is the percentage of profitable transactions made by Mark C. McKenna?
The percentage of profitable transactions made by Mark C. McKenna is 50%.
What is the average return per transaction made by Mark C. McKenna?
The average return per transaction made by Mark C. McKenna is 6.10%.
What stocks does Mark C. McKenna hold?
Mark C. McKenna holds: BHC, RXDX, APGE, SYRE, NAMS stocks.
What was Mark C. McKenna’s latest transaction?
Mark C. McKenna latest transaction was an Uninformative Buy of ―.
What was Mark C. McKenna's most profitable transaction?
Mark C. McKenna’s most profitable transaction was an Informative Sell of BHC stock on August 21, 2019. The return on the trade was 26.80%.
What is Mark C. McKenna's role in Bausch Health Companies?
Mark C. McKenna's role in Bausch Health Companies is President, Salix.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.